CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors

References

• Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008; 180(4):2581–7.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Fujita J. Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. Kidney Int. 2005; 68(5):1940–3.
   PubMedGoogle Scholar
• Klopp AH, Spaeth EL, Dembinski JL, Woodward WA, Munshi A, Meyn RE, . Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res. 2007; 67(24):11687–95.
   PubMedGoogle Scholar
• Kashofer K, Bonnet D. Gene therapy progress and prospects: stem cell plasticity. Gene Ther. 2005; 12(16):1229–34.
   PubMedGoogle Scholar
• Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986; 315(26):1650–9.
   PubMed Web of Science ®Google Scholar
• Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, . Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 2007; 25(2):520–8.
   PubMedGoogle Scholar
• Dwyer RM, Potter-Beirne SM, Harrington KA, Lowery AJ, Hennessy E, Murphy JM, . Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin Cancer Res. 2007; 13(17):5020–7.
   PubMed Web of Science ®Google Scholar
• Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, . Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005; 106 (2):419–27.
   PubMed Web of Science ®Google Scholar
• Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burmester GR, . Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J Cell Biochem. 2007; 101(1):135–46.
   PubMedGoogle Scholar
• Croitoru-Lamoury J, Lamoury FM, Zaunders JJ, Veas LA, Brew BJ. Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. J Interferon Cytokine Res. 2007; 27(1):53–64.
   PubMedGoogle Scholar
• Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, . The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007; 25(7):1737–45.
   PubMed Web of Science ®Google Scholar
• Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006; 24(4):1030–41.
   PubMed Web of Science ®Google Scholar
• Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells. 2008; 26(1):99–107.
   PubMedGoogle Scholar
• Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, . Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells. 2006; 24(5):1254–64.
   PubMed Web of Science ®Google Scholar
• Guo J, Lin G, Bao C, Hu Z, Chu H, Hu M. Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction. J Biomed Sci. 2008; 15(1):89–97.
   PubMedGoogle Scholar
• Li Y, Yu X, Lin S, Li X, Zhang S, Song YH. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun. 2007; 356(3):780–4.
   PubMedGoogle Scholar
• Fiedler J, Brill C, Blum WF, Brenner RE. IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem Biophys Res Commun. 2006; 345(3):1177–83.
   PubMedGoogle Scholar
• Schichor C, Birnbaum T, Etminan N, Schnell O, Grau S, Miebach S, . Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol. 2006; 199(2):301–10.
   PubMedGoogle Scholar
• Ozaki Y, Nishimura M, Sekiya K, Suehiro F, Kanawa M, Nikawa H, . Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells. Stem Cells Dev. 2007; 16(1):119–29.
   PubMedGoogle Scholar
• Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107(5):1761–7.
   PubMed Web of Science ®Google Scholar
• Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 2007; 109(9):4055–63.
   PubMed Web of Science ®Google Scholar
• Chen X, McClurg A, Zhou GQ, McCaigue M, Armstrong MA, Li G. Chondrogenic differentiation alters the immunosuppressive property of bone marrow-derived mesenchymal stem cells, and the effect is partially due to the upregulated expression of B7 molecules. Stem Cells 2007; 25(2):364–70.
   PubMedGoogle Scholar
• Wells CM, Ridley AJ. Analysis of cell migration using the Dunn chemotaxis chamber and time-lapse microscopy. Methods Mol Biol. 2005; 294:31–41.
   PubMedGoogle Scholar
• Guan JL. Cell Migration: Developmental Methods and Protocols. Methods in Molecular Biology 2003; 294:23–29.
   Google Scholar
• Meriane M, Duhamel S, Lejeune L, Galipeau J, Annabi B. Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cells. Stem Cells 2006; 24(11):2557–65.
   PubMedGoogle Scholar
• Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, . Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004; 11(14):1155–64.
   PubMed Web of Science ®Google Scholar
• Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007; 67(13):6304–13.
   PubMed Web of Science ®Google Scholar
• Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, . Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004; 96 (21):1593–603.
   PubMed Web of Science ®Google Scholar
• Xiang J, Tang JQ, Song C, Yang Z, Hirst DG, Zheng QJ, . Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. Cytotherapy. 2009; 26:1–11.
   Google Scholar
• Wang Y, Chen X, Armstrong M, Li G. Survival of xenogeneic bone marrow-derived mesenchymal stem cells in a xeno-transplantation model. J Orthop Res. 2007; 25:926–932.
   PubMedGoogle Scholar
• Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008; 15(10):730–8.
   PubMedGoogle Scholar
• Shi M, Li J, Liao L, Chen B, Li B, Chen L, . Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica. 2007; 92(7):897–904.
   PubMedGoogle Scholar
• Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335–48.
   PubMedGoogle Scholar
• Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell. 1996; 84(3):359–69.
   PubMed Web of Science ®Google Scholar
• Mannello F. Multipotent mesenchymal stromal cell recruitment, migration, and differentiation: what have matrix metalloproteinases got to do with it? Stem Cells. 2006; 24(8):1904–7.
   PubMedGoogle Scholar
• De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, De Waele M, . Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica. 2007; 92(4):440–9.
   PubMed Web of Science ®Google Scholar
• Ip JE, Wu Y, Huang J, Zhang L, Pratt RE, Dzau VJ. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell. 2007; 18(8):2873–82.
   PubMed Web of Science ®Google Scholar
• Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, Klinz FJ, . Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells. 2006; 24(7):1750–8.
   PubMed Web of Science ®Google Scholar
• Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc. 2007; 39(2):573–6.
   PubMedGoogle Scholar
• Kim JM, Lee ST, Chu K, Jung KH, Song EC, Kim SJ, . Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res. 2007; 1183:43–50.
   PubMed Web of Science ®Google Scholar